Cargando…
Triclinic modification of diaquabis(5-carboxy-1H-imidazole-4-carboxylato-κ(2) N (3),O (4))iron(II)
The title compound, [Fe(C(5)H(3)N(2)O(4))(2)(H(2)O)(2)], is a triclinic modification of a monoclinic form recently reported by Du et al. [Acta Cryst. (2011) ▶, E67, m997]. The Fe(II) ion lies at an inversion center and is coordinated by two N and two O atoms from two 5-carboxy-1H-imidazole-4-carbox...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414146/ https://www.ncbi.nlm.nih.gov/pubmed/22904753 http://dx.doi.org/10.1107/S1600536812031753 |
Sumario: | The title compound, [Fe(C(5)H(3)N(2)O(4))(2)(H(2)O)(2)], is a triclinic modification of a monoclinic form recently reported by Du et al. [Acta Cryst. (2011) ▶, E67, m997]. The Fe(II) ion lies at an inversion center and is coordinated by two N and two O atoms from two 5-carboxy-1H-imidazole-4-carboxylate ligands in trans positions, together with two water molecules, completing a slightly distorted octahedral coordination. Intermolecular N—H⋯O hydrogen bonding between the N—H group of the imidazole ring and the deprotonated carboxylate group builds a chain of 5-carboxy-1H-imidazole-4-carboxylate anions along the [101] direction. The water molecules form intermolecular hydrogen bonds to O—C and O=C sites of the carboxylate group in adjacent layers. |
---|